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Abstract
Background: HBV X protein (HBX) is associated with cell apoptosis mediated by TNF-α related apoptosis inducing
ligand (TRAIL), while the role of HBX on the expressions of TRAIL receptors death receptor 4 (DR4) and DR5 are
unclear. In this study, we detected the cell apoptosis induced by TRAIL as well as gene and protein expressions of
DR4 and DR5 in Huh-7 cells steadily transfected with HBX (Huh-7-HBX cells). In addition, we investigated the
activation of different pathways associated with the expressions of TRAIL receptors in Huh-7-HBX cells.
Methods: The apoptosis of Huh-7-HBX cells induced by TRAIL was evaluated by flow cytometry analysis. The levels
of DR4 and DR5 expression in cells were determined by real-time PCR and western blotting analysis. The activities
of JNK pathway and NF-kappaB (NF-κB) pathway were demonstrated by western blotting assay.
Results: Compared to control cells, the percentage of cell apoptosis was increased in Huh-7-HBX cells. The
increased expressions of DR4 and DR5 on gene and protein levels were observed in Huh-7-HBX cells. Further
researches suggested that activation of JNK pathway was increased but not involved in the expression of TRAIL
receptors in HBX positive cells. The activation of NF-κB pathway increased and was responsible for DR5 expression
and cell apoptosis in HBX positive cells.
Conclusions: These results demonstrate that increased apoptosis induced by TRAIL is associated with increased
expression of DR5 that mediated by HBX through NF-κB pathway. This finding provides a critical insight into the
mechanism of hepatocyte apoptosis mediated by HBX in HBV infection.
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Background
Hepatitis B virus (HBV) infection is responsible for
chronic hepatitis, cirrhosis and hepatocellular carcinoma
(HCC) [1]. Among the proteins encoded by the viral
genome, hepatitis B virus X (HBX) protein has been
found to play a crucial role in pathogenesis of HCC.
Accumulating evidences suggest that HBX protein not
only could activate transcription factors, such as nuclear
factor-κB (NF-κB) and activator protein 1 (AP-1) [2–4],
but also interact with different cellular oncogenes, includ-
ing Ras and Src to enhance cell proliferation, migration,
invasion and metastasis [5, 6]. HBX also has the function
of stimulating Wnt, Ras/MAPK, and PI3K-Akt/PKB path-
way to mediate the expression of cellular proteins with
various biological activities [7, 8]. In addition, our labora-
tory and other researchers reported that HBX was in-
volved in mediating cell apoptosis by the death receptor
pathway or mitochondrial dependent pathway [9–12].
TNF-α related apoptosis inducing ligand (TRAIL) is a
member of the TNF (tumor necrosis factor) superfamily
that can induce cell apoptosis mainly in tumor cells.
Until now, five receptors of TRAIL have been reported,
but only death receptors TRAIL-R1 (DR4) and TRAIL-
R2 (DR5) have cytoplasmic death domains to induce cell
apoptosis. TRAIL-R3, TRAIL-R4 and osteoprotegerin
lack the functional death domains but are capable of
blocking apoptosis mediated by TRAIL [13]. After the
binding of TRAIL with death receptors, caspase-8 and
caspase-10 are recruited and form a death-inducing sig-
naling complex (DISC) to transduce apoptotic signal.
Current studies reported that HBX could increase TRAIL
induced apoptosis by up-regulating of Bax protein or
increasing TRAIL expression in hepatoma cells [14, 15].
But the role of TRAIL receptors in HBX-mediated apop-
tosis through TRAIL is largely unknown.
In this study, we propose that the HBX maybe induce
the abnormal expression of death receptors to partici-
pate in cell apoptosis induced by TRAIL. We assessed
the expression of DR4 and DR5 in HBX positive hepa-
toma cells and provided a new insight into the mechan-
ism of DR5 expression mediated by HBX.
Results
The effect of HBX on cell apoptosis induced by TRAIL
To investigate the role HBX on apoptosis of hepatoma
cell line Huh-7 cell with the induction of TRAIL, HBX
expressing plasmid pcDNA3.1-X was transfected into
Huh-7 cells (named as Huh-7-HBX cells). The Huh-7
cells transfected with plasmid pcDNA3.1 was used as
control cells (Huh-7-Mock cells). Real-time PCR and
western blotting analysis demonstrated that Huh-7 cells
transfected with pcDNA3.1-X could steadily express
HBX gene and protein (Fig. 1a-b). Then Huh-7-HBX
cells and control cells were incubated with TRAIL for
24 h, and the cell apoptosis was detected by flow cytom-
etry. The results showed that the percentage of cell
apoptosis of Huh-7-HBX cells was significant higher
than that of control cells (Fig. 1c), suggesting that HBX
could promote the cell apoptosis induced by TRAIL.
Fig. 1 The apoptosis of Huh-7-HBX cells induced by TRAIL. a, b The expression of HBX in HepG2 cells was determined by RT-PCR and western
blotting analysis. c After the cells treated with 100 ng/mL TRAIL for 24 h, the detection of apoptosis of Huh-7-HBX cells and control cells by
flow cytometry
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The role of HBX on induction of death receptors
expression
Considering that the cell apoptosis induced by TRAIL
was based on the interaction of TRAIL with the recep-
tors DR4 and DR5, we detected the expressions of DR4
and DR5 on gene and protein levels in Huh-7-HBX cells
and control cells. The results showed that, compared with
control cells, not only the gene expression of DR4 and
DR5 but also protein expression of these receptors were
significant higher in HBX-Huh-7 cells than in control cells
(Fig. 2a-b), suggesting that HBX could upregulate the
expressions of DR4 and DR5 in hepatoma cells. In order
to explore whether HBV could mediate the expressions of
DR4 and DR5, we transfected the pUC18-HBV1.2, a plas-
mid contains the full-length HBV DNA, into Huh-7 cells
(named as Huh-7-HBV cells) (Fig. 2c), and the results
showed increased expressions of DR4 and DR5 on mRNA
and protein levels in HBV positive cells (Fig. 2d-e).
Furthermore, when the pUC18-HBV-1.2 plasmid and pSi-
lencer3.1-shHBX, a plasmid could inhibit the expression
of HBX, were cotransfected into Huh-7 cells (named as
Huh-7-HBV-siHBX) (Fig. 2f), the expressions of DR4 and
DR5 were decreased (Fig. 2g-h). Taken together, these
results suggested that the increased expressions of DR4
and DR5 induced by HBV were mainly dependent on
HBX in Huh-7 cells.
The effect of different pathways on the DR4 and DR5
expression mediated by HBX
Pervious researches showed that the expressions of DR4
and DR5 were mediated by different pathways such as JNK
pathway and NF-kappa B (NF-κB) pathway [16–19]. We
measured the phosphorylation levels of JNK in Huh-7-
HBX cells and control cells. Compared to control cells, in-
creased phosphorylation level of JNK was observed in
Huh-7-HBX cells (Fig. 3a). Then we treated the cells with
JNK inhibitor (SP600125) for 24 h. The results indicated
that though SP600125 could inhibit the levels of JNK phos-
phorylation in Huh-7-HBX cells, the expression of DR4
and DR5 on mRNA and protein levels had no significant
change in the HBX positive cells (Fig. 3c). These results
suggested that activation of JNK pathway could be medi-
ated by HBX, but it had no role on expressions of DR4 and
DR5 in Huh-7-HBX cells.
We next detected the role of NF-κB pathway on expres-
sions of DR4 and DR5 in Huh-7-HBX cells. The result
showed that the activation of NF-κB (phosphorylation of
P65) pathway increased in Huh-7-HBX cells, compared to
control cells (Fig. 3b). When treated the cells with NF-κB
inhibitor (BAY11-7082) for 24 h, the activation of NF-κB
pathway declined in HBX-Huh-7 cells (Fig. 3d). Mean-
while, the expression of DR5 but not DR4 also decreased
in HBX-Huh-7 cells, suggesting the NF-κB pathway played
an important role on expression of DR5 mediated by HBX
in hepatoma cells.
The role of NF-κB pathway on cell apoptosis mediated by
TRAIL in Huh-7-HBX cells
In order to investigate whether the apoptosis of Huh-7-
HBX cells mediated by TRAIL was dependent on DR4
and DR5, we constructed the specific short hairpin RNA
(shRNA) vectors for DR4 and DR5. When transfected
these shRNA vectors into Huh-7-HBX cells, the expres-
sions of DR4 and DR5 proteins were significantly inhib-
ited (Fig. 4a). Moreover, the apoptosis of Huh-7-HBX
cells was decreased when transfection of shRNA plas-
mids for DR4 and DR5, compared to Huh-7-HBX cells
and Huh7-HBX cells transfected with control vectors
(Fig. 4b). Taken together, these results indicated that the
apoptosis induced by TRAIL in Huh-7-HBX cells was
mainly relied on DR4 and DR5.
Given that NF-κB pathway is responsible for the
expression of DR5 in Huh-7-HBX cells, we next detected
the role of NF-κB pathway on apoptosis of Huh-7-HBX
cells treated with TRAIL. As in Fig. 4c shown, when cells
co-treated with TRAIL and BAY11-7082 for 24 h, the
rates of cell apoptosis decreased in HBX-Huh-7 cells.
While the BAY11-7082 did not have a significant influ-
ence on apoptosis of control cells induced by TRAIL.
Taken together, these results suggested that the NF-κB
pathway contributed to the cell apoptosis mediated by
TRAIL in Huh-7-HBX cells.
Discussion
The cell apoptosis induced by TRAIL have been investi-
gated in HBX positive hepatocytes or hepatoma cells.
While the role of TRAIL receptors on HBX-mediated
apoptosis had not be well identified. In this study, we
found the upregulation of DR4 and DR5 mediated HBX
was associated with apoptosis of hepatoma cells treated
with TRAIL. In addition, the activation of NF-κB was
responsible for the expression of DR5 mediated by HBX
and promoted the cell apoptosis induced by TRAIL in
HBX positive hepatoma cells.
Consistent with previous researches, we found that
HBX sensitized the cells to apoptosis induced by TRAIL.
Liang X et al reported that HBX strengthened TRAIL-
induced apoptosis of hepatocytes through increasing the
expression of Bax, a protein associated with cell apop-
tosis mediated by mitochondria-dependent pathway [14].
In addition, Yang Y et al showed that the apoptosis me-
diated by HBX was associated with increased expression
of TRAIL induced by HBX in hepatocytes [15]. While
the apoptosis mediated by TRAIL was based on the
binding of TRAIL with its receptors. The apoptosis
mediated by HBX in hepatocytes maybe associated with
TRAIL receptors. In addition, increased expression of
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Fig. 2 The expressions of DR4 and DR5 mediated by HBX. a The expressions of DR4 and DR5 mRNA detected by real-time PCR in Huh-7-HBV cells
and control cells. b The expressions of DR4 and DR5 proteins determined by western blotting analysis in Huh-7-HBV cells and control cells. To
detect the role of HBV on DR4 and DR5 expressions, Huh-7 cells were transfected with pUC18-HBV1.2 or control plasmid. Forty-eight hours after
transfection, the expressions of HBX and HBsAg genes (c), the expressions of DR4 and DR5 were detected on mRNA levels (d) and protein levels
(e) were measured. The Huh-7 cells transfected with pUC18-HBV1.2 was named as Huh-7-HBV cells, and the cells transfected with control plasmid
was as Huh-7-HBV-CON cells. In order to test the role of HBX on the expressions of DR4 and DR5 mediated by HBV, Huh-7 cells were
cotransfected pUC18-HBV1.2 with pSilencer3.1-shHBX or control plasmid. Forty-eight hours after transfection, the expressions of HBX, HBsAg as well as
DR4 and DR5 were detected on mRNA levels with detected by RT-PCR (f) and real-time PCR (g), and protein levels measured by western blotting
analysis (h). The Huh-7 cells cotransfected with pUC18-HBV1.2 with pSilencer3.1-shHBX were named as Huh-7-HBV-siHBX cells. The Huh-7 cells
cotransfected with pUC18-HBV1.2 with control plasmid of pSilencer3.1-shHBX were as Huh-7-HBV-siCON cells
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DR4 was observed in hepatoma cell line HepG2 trans-
fected with HBV by Janssen HL et al [20], and the observa-
tion enhance our hypothesis that HBX could increase the
sensitivity of cell apoptosis induced by TRAIL receptors.
Among the TRAIL receptors, only DR4 and DR5 have
cytoplasmic death domains and induce cell apoptosis by
interacting with TRAIL. We tested the expressions of
DR4and DR5 in HBX positive hepatoma cells and the re-
sults were consistent with our hypothesis that HBX could
induce DR4 and DR5 expression in Huh-7-HBX cells. In
addition, we found that HBV was capable of inducing the
expressions of DR4 and DR5, and HBX was responsible
for the increased expressions of DR4 and DR5 mediated
by HBV.
We next investigated the mechanism of increased
expression of DR4 and DR5 induced by HBX. Previous
studies indicated that expressions of DR4 and DR5 could
be mediated by JNK-dependent pathway [16, 17]. Con-
sistent with our previous researches, we observed
increased phosphorylation levels of JNK in HBX positive
cells [9]. But when we inhibit JNK-dependent pathway
with SP600125, the expressions of DR4 and DR5 were
not decreased in HBX-Huh-7 cells. These results sug-
gested that the increased expression induced by HBX
Fig. 3 The roles of JNK and NF-κB pathways on expressions of DR4 and DR5 proteins in Huh-7-HBX cells. a The activation of JNK pathways induced by
HBX. b The activation of NF-κB pathways induced by HBX. c The role of JNK pathways on expression of DR4 and DR5 proteins induced by HBX.
Huh-7-HBX and control cells were cultured in 0.01 % dimethyl sulfoxide (DMSO) in the absence or presence of 20 μM SP600125 for 24 h. Then the
expressions of DR4 and DR5 proteins were detected by western blotting analysis. d The role of NF-κB pathways on expressions of DR4 and DR5
proteins induced by HBX. Huh-7-HBX and control cells were cultured in 0.01 % dimethyl sulfoxide (DMSO) in the absence or presence of 10 μM
BAY11-7082 for 24 h, and then the expressions of DR4 and DR5 proteins were detected by western blotting analysis
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Fig. 4 The role of NF-κB pathways on apoptosis of Huh-7-HBX cells induced by TRAIL. a Huh-7-HBX cells was transfected with shRNA plasmids for
DR4 and DR5, and 48 h post-transfection, the expression of DR4 and DR5 proteins was measured by western blotting analysis. Huh-7-HBX cells
transfected with control plasmid of shRNA were named as siCON cells, Huh-7-HBX cells transfected with shRNA plasmids for DR4 and DR5 (pGPU6/
GFP/Neo-DR4 and pGPU6/GFP/Neo-DR5) were as siRNA cells. b After Huh-7-HBX cells transfected with shRNA plasmids for DR4 and DR5, and control
plasmids for 48 h, the apoptosis was detected in Huh-7-Mock cells, Huh-7-HBX cells, and Huh-7-HBX cells transfected with different plasmids. c After
the cells treated with 100 ng/mL TRAIL and 10 μM BAY11-7082 for 24 h, the apoptosis of cells was detected by flow cytometry analysis
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was not dependent on the activation of JNK pathway.
NF-κB pathway was also reported to be responsible for
expression of DR4 and DR5 [18, 19]. Furthermore,
current researches suggested that activation of NF-κB
pathway could be induced by HBX and associated with
the abnormality of various biological activities in HBV
infection [4, 21–23]. We detected the activation of
NF-κB in cells of different groups and found enhanced
phosphorylation level of NF-κB in HBX positive cells.
Inhibition of NF-κB with BAY11-7082 could reduce the
expression of DR5, suggesting that the increased expres-
sion of DR5 mediated by HBX was associated with NF-
κB-dependent pathway.
With the use of shRNAs against DR4 and DR5, we
demonstrated the apoptosis of HBX positive cells medi-
ated by TRAIL was dependant on DR4 and DR5. More-
over, NF-κB pathway that responsible for the upregulation
of DR5 was found to contribute to the increase of HBX
positive cell apoptosis mediated TRAIL, while inhibition
of NF-κB pathway have no significant effect on apoptosis
of control cells. Considering the important role of DR4,
DR5 and NF-κB pathway in HBX positive cells, targeting
these proteins or pathway may be a potential treatment
strategy to correct the abnormal biological activity includ-
ing the cell apoptosis mediated by HBX.
Conclusion
In summary, we demonstrated that increased apoptosis
induced by TRAIL was associated with increased expres-
sion of DR5 that mediated by HBX through NF-κB path-
way. This finding provided a critical insight into the




The plasmid pcDNA3.1-X, which contains the full length
HBX sequence, and pSilencer3.1-shHBX, a vector for
shRNA targeting HBX, were constructed previously [9].
The pGPU6/GFP/Neo plasmids encoding specific shRN
As against DR4 (GCTGTTCTTTGACAAGTTTGC) and
DR5 (GCAA GTCTTTACTGTGGAAGA), named as
pGPU6/GFP/Neo-DR4 and pGPU6/GFP/Neo-DR5, were
purchased from GenePharma Co., Ltd (Suzhou, Jiangsu,
China). The pUC18-HBV1.2 plasmid is a gift from Dr.
Xiaoben Pan [24]. The rabbit polyclonal antibody against
human DR4, and rabbit polyclonal antibody against hu-
man DR5 were obtained from Abcam (Cambridge, MA,
USA). Recombinant solution human TRAIL was obtained
from TeproTech (Rocky Hill, NJ, USA). Mouse anti-HBX
polyclonal antibody and Immibilon Western Chemilumin-
escent HRP Substrate were purchased from Millpore
(Billerica, MA, USA). Rabbit polyclonal antibody against
JNK, rabbit polyclonal antibody against phosphorylated-
JNK (p-JNK), rabbit polyclonal antibody against NF-κB
P65, rabbit polyclonal antibody against phosphorylated-
NF-κB P65 (p-P65), chemistry inhibitor of JNK (SP600125)
and NF-κB (BAY11-7082) were purchased from Sigma-
Aldrich (St Louis, MO, USA). Antibodies mouse anti-
human β-actin and mouse anti-human Tubulin were
purchased from Santa Cruz Biotechnolog (Santa Cruz, CA,
USA). G418 was from promega (Madison, WI, USA).
Trizol reagent was obtained from Invitrogen (Carlsbad,
CA, USA). Annexin V/PI apoptosis kit was from Biovision
(Mountain View, CA, USA). UitraTaq enzyme PCR kit was
obtained from TIANGEN Biotech (Beijing, China). BCA
Protein Assay Kit was from Beyotime Institute of Biotech-
nology (Jiangsu, China). Goat anti-mouse IgG-HRP, goat
anti-rabbit IgG-HRP were purchased from ZSJQ-Bio
(Beijing, China). Rabbit anti-HBsAg polyclonal antibody
was obtained from Bioss Biotechnology (Beijing, China).
Cell culture and plasmids transfection
Human hepatocarcinoma cell line Huh-7 cell, obtained
from the Cell Bank of Chinese Academy of Sciences,
was cultured in DMEM supplemented with 10 % fetal
bovine serum (FBS) at 37 °C in 5 % CO2. Huh-7 cells
cultured in 6-well plates were transfected with plasmid
pcDNA3.1-X (4ug/well), pUC18-HBV1.2 (4ug/well), or
cotransfected pUC18-HBV1.2 (4ug/well) with pSilen-
cer3.1-shHBX (2ug/well), using according to the manufac-
turer’s instructions. Forty-eight hours after transfection,
the cells transfected with pcDNA3.1-X were incubated in
selection medium containing 0.8 mg/ml G418. After the
cells selected with G418 and passed on to 3-5 passages in
a month, the expression of HBX mRNA and protein in
the resistant clones were detected. The cells steadily
expressed with HBX gene and protein were named Huh-
7-HBX cell. Huh-7 cells transfected with pcDNA3.1 empty
plasmid was as control group. When 48 h post-
transfection, these cells transfected with pUC18-HBV1.2
or cotransfected pUC18-HBV1.2 with pSilencer3.1-shHBX
plasmids were harvested, and the mRNA and protein
levels of target genes were measured by RT-PCR, real-
time PCR and western blotting analysis. Huh-7-HBX cells
were transfected with DR4 and DR5 shRNA vectors (2ug/
well of each) by Lipofectamin2000 as followed the manu-
facturer’s instructions. At 48 h after transfection, the ex-
pression of DR4 and DR5 was tested by real-time PCR
and western blotting analysis.
RT-PCR and real-time PCR analysis
The total RNA of different cells was prepared with Trizol
reagent as the manufacturer’s described. The reverse tran-
scription was performed with TIANScript RT Kit. Primer
sequences used for detection of HBX were TGTGAAG
CTTATGGCTGCTAGGC and TGTGGAATTCTTAGG-
CAGAGGTG. Primers for HBsAg were CATCTTCTTG
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TTGGTTCTTCTG and TTAGGGTTT AAATGTATAC
CC. Primers for β-actin amplificaiton were GGCATCGT-
GAT GGACTCCG and GCTGGAAGGTGGACAGCGA.
The UitraTaq enzyme PCR kit was used for PCR reaction
and amplification condition was 94 °C for 5 min, followed
with 94 °C for 40 s, 67 °C for 30 s, 72 for 1 min for 30 cy-
cles and a final extension at 72 for 10 min each. The PCR
products were subjected to electrophoresis in 1 % agarose
gel and visualized by ethidiun bromide staining. The real-
time PCR primers for DR4, DR5 AND GAPDH were
CTGAGCAACGCAGAC TCGCTGTCCAC and TCAAA
GGACACGGCAGAGCCTGTGCCA, GGGAGCCGCT-
CATGAGGAAGTT GG and GGCAAGTCTCTCTCCCA
GCGTCTC, TGGAA GGACTCATGACCACA and TT
CAGCTCAGGGATGACCTT, respectively. The real-time
PCR was performed with a SYBR master mix (Toyobo,
Japan), and amplification conditions were as follows: 94 °C
for 3 min, and followed by 40 cycles of 95 °C for 30s, 60 °C
for 30 s, 72 for 30s. The relative mRNA expression levels
of DR4 and DR5 were normalized based on the GAPDH in
each group.
Western blotting analysis
For protein extracts, cells were lysed in cell lysis buffer
with 1 mM phenylmethanesulfonyl fluoride (PMSF). The
lysates were collected by scraping from the plates, and
then centrifuged at 10,000 g at 4 °C for 10 mins. The
protein concentration was measured by BCA Protein
Assay Kit and adjusted at equal pace, then total protein
was subjected to SDS-PAGE and transferred onto PVDF
membranes, the membranes were blocked with 5 % milk
in TBS containing 0.01 % Tween-20 for 3 h at room
temperature, and incubated with different specific primary
antibodies at 4 °C overnight. Then the membranes were
incubated with goat anti-mouse IgG-HRP, goat anti-rabbit
IgG-HRP separately for 2 h at room temperature. The pro-
tein bands were detected with Immibilon Western Chemi-
luminescent HRP Substrate.
Flow cytometry analysis
After the cells treated with 100 ng/mL TRAIL for 24 h,
1 × 105 cells were collected, and the cell apoptosis was
evaluated by double staining with fluorescein isothiocyan-
ate (FITC)-conjugated Annexin V and propidium iodide
(PI) using annexin V/PI apoptosis kit. The flow cytometry
analysis for cell apoptosis was described previously (9).
Statistical analysis
The data were presented as mean ± standard deviation
(SD). The comparisons in all experiments were per-
formed using Student’s t-tests or one way ANOVA with
SPSS software (version 16.0, SPSS Inc. Chicago, IL, USA).
The p value < 0.05 was considered statistically significant.
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